The aims of treating @entity1 with @entity565 are to relieve symptoms, to prevent symptoms and exacerbations, and to prevent long-term deterioration in lung function. It is the role of medical practitioners to inform the @entity1 what @entity565 is, and to develop a plan to achieve the aims for the individual, recognizing that @entity565 is frequently a chronic, lifelong disease. Most @entity1 can be diagnosed, assessed for severity and causes, and treated in primary care practices, however, sometimes help from an @entity565 clinic of a specialist is required. The most important management decision is to determine whether the @entity1 needs inhaled @entity288 ; subsequently, decisions about dose, duration and method of delivery of treatment can be tailored to the individual depending on the preferences and social conditions of the @entity1 . The aim of this article is to present the latest strategies for the management of @entity565 and the simplest methods for their implementation. Important new strategies include careful assessment of the severity; immediate introduction of a plan that is tailored of the individual and aimed at the possible reversing of the disease; detailed instructions for management of exacerbations and the combined use of inhaled @entity288 with a long-acting bronchodilator. It is becoming clear that these strategies obviate @entity734 on oral @entity288 in newly diagnosed @entity748 @entity1 . Furthermore, relatively low doses of inhaled @entity288 can be used to maintain good control if used in conjunction with other therapies. The role of newly developed antagonists to @entity4443 is not yet known but it may well be useful in mild @entity565 and in special forms of the disease, such as those sensitive to @entity117 . In the future, the most important strategy will be to prevent the disease.

Strategies for the management of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity748 :: ('MESH:D013224', 'Disease') :: ['asthmatic'] @entity4443 :: ('MESH:D015289', 'Chemical') :: ['leukotrienes'] @entity565 :: ('MESH:D001249', 'Disease') :: ['asthma'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity734 :: ('MESH:D019966', 'Disease') :: ['dependence'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids']
@entity565 :: (MESH:D001249,Disease) :: ['asthma']
